Becton, Dickinson and Co. | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Abbott USD 6.53B 1.08B 2025-03
Agilent USD 1.47B 138M 2025-01
Align Technology USD 873.01M 170.88M 2025-03
Avanos Medical USD 97M 10.7M 2025-03
Baxter International USD 1.76B 344M 2024-12
Becton, Dickinson and Co. USD 667M 44M 2025-03
Bio-Rad Laboratories USD 521.4M 33.3M 2025-03
Boston Scientific USD 725M 311M 2025-03
Cooper Companies USD 100.9M 6.7M 2025-01
Danaher USD 1.99B 85M 2025-03
Dentsply International USD 398M 126M 2025-03
Dexcom USD 904.9M 298.8M 2025-03
Edwards Lifesciences USD 3.05B 631.2M 2024-12
Exact Sciences USD 6.11M 773K 2025-03
Globus Medical USD 461.27M 323.17M 2025-03
Hologic USD 1.43B 352.6M 2025-03
Insulet USD 1.01B 194.6M 2025-03
Integra LifeSciences USD 239.1M 7.27M 2025-03
Intuitive Surgical USD 9.1B 268.8M 2025-03
J&J USD 38.47B 32.35B 2025-03
Masimo USD 130.8M 46.8M 2025-03
Medtronic USD 2.22B 978M 2025-04
Solventum Corp 534M 228M 2025-03
Stryker USD 2.32B 1.33B 2025-03
Tandem Diabetes Care USD 53.57M 15.66M 2025-03
Teleflex USD 284.12M 6.07M 2025-03
Terumo JPY 221.87B 9.32B 2025-03
Thermo Fisher Scientific USD 4.13B 125M 2025-03
Zimmer Biomet Holdings USD 525.5M 43.5M 2024-12



Becton, Dickinson and Co. Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.